Results 131 to 140 of about 422,254 (259)
Clinical Images: Skeletal fluorosis presenting with diffuse periostitis and polyarticular synovitis
Arthritis &Rheumatology, EarlyView.
Mitali Sen
wiley +1 more source
Abstract Health care is shifting towards a digital‐guided system, integrating digital diagnostics, biomarkers and therapeutics in many care pathways. However, despite rapid technological advancement and preliminary adoption accelerated by the COVID‐19 pandemic, a significant implementation gap persists. This narrative review explores the causes of this
Mees H. P. Stoop +3 more
wiley +1 more source
Diagnostic and management dilemmas in pulmonary hypertension. [PDF]
Condliffe R +14 more
europepmc +1 more source
Aims Paediatric pharmacokinetics differ significantly from adults due to age‐related physiological changes, necessitating precise dose adjustments. However, data on therapeutic drug monitoring (TDM) implementation in paediatric setting remain limited.
Gianluca Gazzaniga +20 more
wiley +1 more source
Abstract Introduction Active surveillance of adverse events using healthcare data is emerging as complementary to the monitoring of spontaneous reports and stand‐alone pharmacoepidemiologic studies. The risk of urinary tract infections (UTIs) was listed as a special warning for sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) when marketed in Europe
Haoxin Le +5 more
wiley +1 more source
Pulmonary Endothelium: A Driver and Therapeutic Target in Pulmonary Hypertension. [PDF]
Kovacs-Kasa A, Annex BH.
europepmc +1 more source
Background Reporting adverse drug reactions (ADRs) is essential for drug safety. In Switzerland, healthcare professionals are legally required to report serious and unlabelled ADRs, yet under‐reporting remains widespread. We tested a novel method to increase reporting of ADR‐related hospitalizations.
Georgia Anita Weber +7 more
wiley +1 more source
Selexipag for Pulmonary Hypertension, TAVI and more. [PDF]
Erol Ç.
europepmc +1 more source
Aim A prior non‐randomized study suggests that potassium supplementation may improve survival among furosemide initiators, and a randomized trial suggests that salt substitutes containing potassium might lower stroke risk. We conducted a retrospective cohort study using health‐care data to confirm or refute these associations among new users of ...
Thanh Phuong Pham Nguyen +8 more
wiley +1 more source
A Metabolomics Roadmap to Right Ventricular Function in Pulmonary Hypertension. [PDF]
Pi H, Gharib SA, Leary PJ.
europepmc +1 more source

